Despite the genomic heterogeneity, activation of HOXA, MEF2C, or BCL11B, characterize specific subtypes of immature cases, accounting for approximately half of ETP-ALL (Figure 5). The gene discussed is MEF2C; the disease is acute lymphoblastic leukemia.